Literature DB >> 35094311

Molecular profiling of papillary thyroid carcinomas in healthcare workers exposed to low dose radiation at the workplace.

Carlos S Duque1, Alejandro Vélez1,2, Jorge Cuartas3, Fabian Jaimes4, Juan Pablo Dueñas1, Miguel Agudelo5, Marina N Nikiforova6, Yuri E Nikiforov6, Vincenzo Condello7.   

Abstract

PURPOSE: Exposure to ionizing radiation, especially during childhood, is a well-established risk factor for thyroid cancer. The vast majority of radiation-induced cancers are papillary carcinomas (PTCs). These tumors typically have gene fusions in contrast to point mutations prevalent in sporadic PTCs. The aim of this study was to investigate the molecular profiles of PTC patients with workplace exposure to ionizing radiation.
METHODS: A retrospective review of 543 patients who underwent surgery with diagnosis of PTC was performed. A cohort of nine healthcare specialists previously exposed to radiation sources during their professional practice was selected and analyzed using the ThyroSeq mutation panel for point mutations and gene fusions associated with thyroid cancer.
RESULTS: The molecular analysis of surgical samples of PTCs was informative and revealed genetic alterations in five patients. BRAF V600E was found in four (67%) cases whereas RET/PTC1 fusion in one (17%) and one sample (17%) was wild type for point mutations and fusions. One sample completely failed molecular analysis while two others were negative for genes fusions but failed DNA analysis; these three samples were excluded.
CONCLUSIONS: In this limited cohort of healthcare workers exposed to low dose of ionizing radiation at the workplace and developed PTC, the molecular profiling determined BRAF V600E point mutation as the most common event, arguing against the role of workplace radiation exposure in the etiology of these tumors.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Healthcare specialists; Papillary thyroid carcinoma (PTC); Radiation; ThyroSeq; Thyroid cancer

Mesh:

Substances:

Year:  2022        PMID: 35094311     DOI: 10.1007/s12020-021-02972-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  49 in total

1.  Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki.

Authors:  E L SOCOLOW; A HASHIZUME; S NERIISHI; R NIITANI
Journal:  N Engl J Med       Date:  1963-02-21       Impact factor: 91.245

2.  Thyroid cancer in childhood and adolescence; a report on 28 cases.

Authors:  B J DUFFY; P J FITZGERALD
Journal:  Cancer       Date:  1950-11       Impact factor: 6.860

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 4.  Radiation interactions with biological systems.

Authors:  Muhammad Torequl Islam
Journal:  Int J Radiat Biol       Date:  2017-02-13       Impact factor: 2.694

Review 5.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

Review 6.  Familial thyroid cancer: a review.

Authors:  Vânia Nosé
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

7.  Radiation induced thyroid cancer: fundamental and applied aspects.

Authors:  M Tronko; T Bogdanova; L Voskoboynyk; L Zurnadzhy; V Shpak; L Gulak
Journal:  Exp Oncol       Date:  2010-09

8.  Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991-1992) from the Republic of Belarus.

Authors:  Y Nikiforov; D R Gnepp
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

Review 9.  Ionising radiation and cancer risks: what have we learned from epidemiology?

Authors:  Ethel S Gilbert
Journal:  Int J Radiat Biol       Date:  2009-06       Impact factor: 2.694

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.